These Were The Most Actively Traded Stocks On The OTC Markets In February
As we highlighted last month, preferred shares of Fannie Mae and Freddie Mac experienced dramatic increases in dollar trading volume to start 2019. That was not the case in February however, as dollar volume in the mortgage liquidity providers receded back to normal levels.
While different share classes of Fannie and Freddie did occupy seven of the top 12 most-active securities on the OTCQB Venture market in February, they all experienced month-over-month declines in dollar trading volume compared to January. Dollar volume in shares of Fannie Mae (OTCQB: FNMAS), Fannie Mae (OTCQB: FNMA), Freddie Mac (OTCQB: FMCKJ), and Freddie Mac (OTCQB: FMCC) fell an average of 57 percent month-over-month.
This trend continued across many of the largest securities on OTC Markets in February, particularly among large multinationals. Of the most actively traded securities on the OTCQX Best Market (the top tier of OTC Markets), international conglomerates Roche Holding Ltd (OTCQX: RHHBY), adidas AG (OTCQX: ADDYY), Danone (OTCQX: DANOY), and BNP Paribas (OTCQX: BNPQY) all experienced lower dollar volume in February compared to January.
That’s not to say there are not OTCQX securities that didn’t experience volume increases in the month. Dollar volume in Mexican banking group Grupo Financiero Banorte, S.A.B. De C.V. (OTCQX: GBOOY) increased 125 percent in February, and Dutch health multinational Royal DSM NV (OTCQX: RDSMY) rose 109 percent.
Interestingly, the Grayscale Bitcoin Trust (BTC) (OTCQX: GBTC) and Organigram Holdings, Inc. (OTCQX: OGRMF)—two securities that represent emerging industries—saw increases of 9 and 56 percent in February, suggesting investors had more of a risk-on appetite during the month.
Similarly, three cannabis companies on the OTCQB Venture Market saw massive dollar volume increases in February. Khiron Life Sciences Corp. (OTCQB: KHRNF), Leafbuyer Technologies, Inc. (OTCQB: LBUY), and Plus Products Inc. (OTQB: PLPRF) saw dollar volume increases of 277 percent, 157 percent, and 810 percent respectively.
Overall, volume was down among most of the larger names on OTCQB. Of the 10 most actively traded securities on the OTCQB Market in February, only NaturalShrimp Incorporated (OTCQB: SHMP) (up 1,713 percent), Cleanspark, Inc. (OTCQB: CLSK) (up 916 percent) and one class of Fannie Mae (OTCQB: FNMAT) (up 165 percent) saw their dollar trading volume increase from January.
Here’s a list of the top 12 most actively traded securities on the OTCQX and OTCQB Markets in February.
OTCQX:
Roche Holding Ltd (OTCQX: RHHBY) | Switzerland | $1,079,606,596 | $911,092,701 | ||
Grayscale Bitcoin Trust (OTCQX: GBTC) | U.S. | $161,681,343 | $175,629,021 | ||
adidas AG (OTCQX: ADDYY) | Germany | $169,355,902 | $136,490,312 | ||
Danone (OTCQX: DANOY) | France | $204,292,004 | $122,847,380 | ||
Organigram Holdings, Inc. (OTCQX: OGRMF) | Canada | $74,363,433 | $116,218,207 | ||
Grupo Financiero Banorte, S.A.B. De C.V. (OTCQX: GBOOY) | Mexico | $51,073,673 | $114,910,856 | ||
BNP Paribas (OTCQX: BNPQY) | France | $146,710,509 | $106,827,223 | ||
Royal DSM NV (OTCQX: RDSMY) | The Netherlands | $44,813,473 | $93,439,380 | ||
AXA (OTCQX: AXAHY) | France | $161,375,225 | $92,781,899 | ||
Medmen Enterprises Inc. (OTCQX: MMNFF) | U.S. | $71,646,472 | $89,078,239 | ||
BASF SE (OTCQX: BASFY) | Germany | $222,497,371 | $84,525,424 | ||
Imperial Brands PLC (OTCQX: IMBBY) | United Kingdom | $248,207,558 | $83,766,246 |
OTCQB
Fannie Mae (OTCQX: FNMAS) | U.S. | $619,571,945 | $296,092,206 | ||
Fannie Mae (OTCQB: FNMA) | U.S. | $828,721,292 | $291,190,951 | ||
Freddie Mac (OTCQB: FMCKJ) | U.S. | $470,164,203 | $218,477,784 | ||
NaturalShrimp Incorporated (OTCQB: SHMP) | U.S. | $11,559,867 | $209,621,992 | ||
Freddie Mac (OTCQB: FMCC) | U.S. | $343,034,008 | $138,365,957 | ||
KushCo Holdings, Inc. (OTCQB: KSHB) | U.S. | $174,152,341 | $98,619,481 | ||
CV Sciences, Inc. (OTCQB: CVSI) | U.S. | $104,212,212 | $68,246,738 | ||
Cleanspark, Inc. (OTCQB: CLSK) | U.S. | $6,372,806 | $64,723,666 | ||
Fannie Mae (OTCQB: FNMAT) | U.S. | $20,891,849 | $55,267,374 | ||
Fannie Mae (OTCQB: FNMFN) | U.S. | $29,382,633 | $47,132,741 | ||
Khiron Life Sciences Corp. (OTCQB: KHRNF) | Canada | $9,640,467 | $36,359,699 | ||
Fannie Mae (OTCQB: FMCKM) | U.S. | $11,796,584 | $33,308,472 |
See more from Benzinga
SEC Commissioner Jackson: Buybacks Coincide With Increased Insider Selling
What Fintech Platform MoneyLion Hopes To Gain By Bringing Attention To The Gender Pay Gap
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
